Me
Non verificato

Merck

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute
21/05/2026
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Industria
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
Fonte
1.00
12/01/2026
Eventi
Industria
Salute
Farmaceutica
Medicina - Varie
Oncologia
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Fonte
1.00
12/01/2026
Eventi
Industria
Salute
Farmaceutica
Medicina - Varie
Oncologia
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Fonte
1.00
22/12/2025
Oncologia
Auto/Automotive
Salute
Sanità
Farmaceutica
Industria
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
Fonte
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0